The University of Chicago Header Logo

Connection

Robert Rosenfield to Polycystic Ovary Syndrome

Back to Details
This is a "connection" page, showing publications Robert Rosenfield has written about Polycystic Ovary Syndrome.
Robert Rosenfield
Connection Strength
9.983
Polycystic Ovary Syndrome
  1. Normal and Premature Adrenarche. Endocr Rev. 2021 11 16; 42(6):783-814.
    View in: PubMed
    Score: 0.701
  2. Current concepts of polycystic ovary syndrome pathogenesis. Curr Opin Pediatr. 2020 10; 32(5):698-706.
    View in: PubMed
    Score: 0.649
  3. Perspectives on the International Recommendations for the Diagnosis and Treatment of Polycystic Ovary Syndrome in Adolescence. J Pediatr Adolesc Gynecol. 2020 Oct; 33(5):445-447.
    View in: PubMed
    Score: 0.637
  4. Letter to the Editor: "Normal Pubertal Development in Daughters of Women With PCOS: A Controlled Study". J Clin Endocrinol Metab. 2017 07 01; 102(7):2560.
    View in: PubMed
    Score: 0.518
  5. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev. 2016 10; 37(5):467-520.
    View in: PubMed
    Score: 0.486
  6. The Diagnosis of Polycystic Ovary Syndrome in Adolescents. Pediatrics. 2015 Dec; 136(6):1154-65.
    View in: PubMed
    Score: 0.464
  7. Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood. J Clin Endocrinol Metab. 2015 Apr; 100(4):1537-43.
    View in: PubMed
    Score: 0.439
  8. The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum. J Pediatr Adolesc Gynecol. 2015 Dec; 28(6):412-9.
    View in: PubMed
    Score: 0.425
  9. Clinical review: Adolescent anovulation: maturational mechanisms and implications. J Clin Endocrinol Metab. 2013 Sep; 98(9):3572-83.
    View in: PubMed
    Score: 0.395
  10. Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries. Fertil Steril. 2012 Jul; 98(1):242-9.
    View in: PubMed
    Score: 0.362
  11. Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test. Hum Reprod. 2011 Nov; 26(11):3138-46.
    View in: PubMed
    Score: 0.346
  12. Mutations of the hexose-6-phosphate dehydrogenase gene rarely cause hyperandrogenemic polycystic ovary syndrome. Steroids. 2011 Jan; 76(1-2):135-9.
    View in: PubMed
    Score: 0.326
  13. Characterization of functionally typical and atypical types of polycystic ovary syndrome. J Clin Endocrinol Metab. 2009 May; 94(5):1587-94.
    View in: PubMed
    Score: 0.290
  14. Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population. J Clin Endocrinol Metab. 2009 May; 94(5):1579-86.
    View in: PubMed
    Score: 0.290
  15. What every physician should know about polycystic ovary syndrome. Dermatol Ther. 2008 Sep-Oct; 21(5):354-61.
    View in: PubMed
    Score: 0.281
  16. Does a primary acceleration of LH pulse frequency underlie an association between central precocious puberty and polycystic ovary syndrome? Commentary on Escobar ME et al: Acceleration of LH pulse frequency in adolescent girls with a history of central precocious puberty with versus without hyperandrogenism (Horm Res 2007;68:278-285). Horm Res. 2007; 68(6):286-7.
    View in: PubMed
    Score: 0.258
  17. Intractable early childhood obesity as the initial sign of insulin resistant hyperinsulinism and precursor of polycystic ovary syndrome. J Pediatr Endocrinol Metab. 2007 Jan; 20(1):41-51.
    View in: PubMed
    Score: 0.250
  18. Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab. 2007 Mar; 92(3):787-96.
    View in: PubMed
    Score: 0.250
  19. Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome. J Clin Endocrinol Metab. 2006 Apr; 91(4):1275-83.
    View in: PubMed
    Score: 0.235
  20. Identification of a functional polymorphism of the human type 5 17beta-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006 Jan; 91(1):270-6.
    View in: PubMed
    Score: 0.231
  21. Polycystic ovary syndrome in adolescence. Endocrinol Metab Clin North Am. 2005 Sep; 34(3):677-705, x.
    View in: PubMed
    Score: 0.228
  22. Polycystic ovary syndrome and insulin-resistant hyperinsulinemia. J Am Acad Dermatol. 2001 Sep; 45(3 Suppl):S95-104.
    View in: PubMed
    Score: 0.173
  23. Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism. J Pediatr Endocrinol Metab. 2000; 13 Suppl 5:1285-9.
    View in: PubMed
    Score: 0.154
  24. Ovarian and adrenal function in polycystic ovary syndrome. Endocrinol Metab Clin North Am. 1999 Jun; 28(2):265-93.
    View in: PubMed
    Score: 0.148
  25. Role of cytochrome P450c17 in polycystic ovary syndrome. Mol Cell Endocrinol. 1998 Oct 25; 145(1-2):111-21.
    View in: PubMed
    Score: 0.142
  26. Is polycystic ovary syndrome a neuroendocrine or an ovarian disorder? Clin Endocrinol (Oxf). 1997 Oct; 47(4):423-4.
    View in: PubMed
    Score: 0.132
  27. Current concepts of polycystic ovary syndrome. Baillieres Clin Obstet Gynaecol. 1997 Jun; 11(2):307-33.
    View in: PubMed
    Score: 0.129
  28. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev. 1995 Jun; 16(3):322-53.
    View in: PubMed
    Score: 0.112
  29. Gonadotropin-releasing hormone agonist as a probe for the pathogenesis and diagnosis of ovarian hyperandrogenism. Ann N Y Acad Sci. 1993 May 28; 687:162-81.
    View in: PubMed
    Score: 0.097
  30. Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. J Clin Endocrinol Metab. 2012 Jul; 97(7):E1342-7.
    View in: PubMed
    Score: 0.090
  31. Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity. Brain Res. 2010 Dec 10; 1364:186-97.
    View in: PubMed
    Score: 0.081
  32. Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. Fertil Steril. 1990 May; 53(5):785-91.
    View in: PubMed
    Score: 0.079
  33. The polycystic ovary syndrome: pathogenesis and treatment. Ann Intern Med. 1989 Mar 01; 110(5):386-99.
    View in: PubMed
    Score: 0.073
  34. Lipid cell tumor of the ovary in reference to adult-onset congenital adrenal hyperplasia and polycystic ovary syndrome. A case report. J Reprod Med. 1987 May; 32(5):363-9.
    View in: PubMed
    Score: 0.064
  35. Functional significance of polycystic-size ovaries in healthy adolescents. J Clin Endocrinol Metab. 2006 Oct; 91(10):3786-90.
    View in: PubMed
    Score: 0.061
  36. Clinical practice. Hirsutism. N Engl J Med. 2005 Dec 15; 353(24):2578-88.
    View in: PubMed
    Score: 0.058
  37. Plasma free testosterone in the diagnosis of adolescent polycystic ovary syndrome. J Pediatr. 1983 Mar; 102(3):461-4.
    View in: PubMed
    Score: 0.048
  38. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001 Dec; 86(12):5925-33.
    View in: PubMed
    Score: 0.044
  39. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999 Jan; 22(1):141-6.
    View in: PubMed
    Score: 0.036
  40. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997 Jul; 82(7):2108-16.
    View in: PubMed
    Score: 0.032
  41. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997 Feb; 82(2):524-30.
    View in: PubMed
    Score: 0.031
  42. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest. 1995 Jul; 96(1):520-7.
    View in: PubMed
    Score: 0.028
  43. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 1992 Jul 16; 327(3):157-62.
    View in: PubMed
    Score: 0.023
  44. Hyperandrogenism in peripubertal girls. Pediatr Clin North Am. 1990 Dec; 37(6):1333-58.
    View in: PubMed
    Score: 0.021
  45. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics. 2009 Apr; 123(4):e752-62.
    View in: PubMed
    Score: 0.018
  46. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med. 1989 Mar 02; 320(9):559-65.
    View in: PubMed
    Score: 0.018
  47. Evaluation of women with hirsutism. Compr Ther. 1983 Feb; 9(2):25-32.
    View in: PubMed
    Score: 0.012
  48. Ovarian hyperandrogenism with normal and abnormal histologic findings of the ovaries. Am J Obstet Gynecol. 1979 Jun 15; 134(4):445-52.
    View in: PubMed
    Score: 0.009
  49. Relationship of androgens to female hirsutism and infertility. J Reprod Med. 1973 Sep; 11(3):87-95.
    View in: PubMed
    Score: 0.006
  50. The measurement of urinary testosterone glucuronide by competitive protein binding and validation by a double isotope derivative assay. Steroids. 1969 Feb; 13(2):227-45.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.